N/A
N=40
Prophylactic nCPAP Following Bowel Surgery (Bio-REB File 11-27)
Postoperative Pulmonary Atelectasis · Surgery
Bottom Line
View on ClinicalTrials.gov: NCT01316575 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Feb 2013
Primary outcome: Primary: Alveolar - Arterial Gradient — 70.6; 134 torr
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- nCPAP (Device); Low Flow Oxygen (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Saskatchewan
- Primary completion
- May 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Alveolar - Arterial Gradient |
70.6; 134 | — |
| SECONDARY Number of Participants Requiring Reintubation |
0; 0 | — |
| SECONDARY Number of Participants Requiring Admission to ICU |
0; 0 | — |
| SECONDARY Length of Stay in Hospital |
10; 10.9 | — |
Summary
The purpose of this study is to determine whether prophylactic nasal continuous positive airway pressure (nCPAP) in the post-anaesthesia care unit (PACU) improves post-operative pulmonary function following elective bowel surgery. The investigators hypothesize that one hour of nCPAP in the PACU will result in a higher partial pressure of arterial oxygen (PaO2) when compared to the standard treatment of low flow oxygen applied by face mask.
Eligibility Criteria
Inclusion Criteria
- Patients scheduled to undergo elective laparotomy for bowel surgery
Exclusion Criteria
- age < 18 years
- postoperative admission to the intensive care unit
- a history of allergy/intolerance to Ametop
Data sourced from ClinicalTrials.gov (NCT01316575). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.